Silky Overseas Fund Raise of ₹1.32 Cr

Silky Overseas Annual General Meeting

Silky Overseas Limited submitted the minutes of its 10th Annual General Meeting held on September 21, 2026.

Silky Overseas Other Announcement

Silky Overseas Limited filed its quarterly SDD Compliance Certificate as required under SEBI's Prohibition of Insider Trading Regulations.

Silky Overseas Annual General Meeting

Silky Overseas Limited conducted its 10th Annual General Meeting on September 21, 2026. The company discussed financial performance and approved the appointments of its directors.

Silky Overseas Other Announcement

Silky Overseas Limited issued a notice to shareholders with unregistered emails regarding Annual Report accessibility. It also reminded physical shareholders to update their KYC details.

Silky Overseas Annual General Meeting

Silky Overseas Limited will hold its 10th Annual General Meeting on September 21, 2026. The agenda includes financial statement adoption and director appointments.

Silky Overseas Q1 FY27 Results: Net Profit ₹0.8 Cr, Down 71.4% YoY

Silky Overseas Ltd reported revenue from operations of ₹17.1 Cr (-32.4% YoY) and net profit of ₹0.8 Cr (-71.4% YoY) for Q1 FY27.

Key figure

Net profit ₹0.8 Cr · -71.4% YoY

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.